Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Laparoscopic transabdominal retromuscular repair with hernia sac-assisted mesh coverage for incisional ventral hernia: a prospective case series with preliminary outcomes.

Journal of minimally invasive surgery·2026

Same author

Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance.

Molecular aspects of medicine·2026

Same author

Role of Odour Perception in Health and Disease.

The European journal of neuroscience·2026

Same author

The Ayurvedic Anger Assessment Scale: An integrative approach for measuring anger in adults.

Journal of Ayurveda and integrative medicine·2026

Same author

The effect of diode laser with PRP and pelvic floor chair for treatment of stress urinary incontinence in women.

Bioinformation·2025

Same author

Enhancing atomization and spray patterns of spray G in a gasoline direct injection system using biofuel blends with gasoline.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: May 30, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Tiny non-coding RNAs in Parkinson's disease: implications, expectations and hypes.

Garima Srivastava¹, Anubhuti Dixit, Om Prakash

¹Indian Institute of Toxicology Research (Council of Scientific and Industrial Research), Mahatma Gandhi Marg, Post Box 80, Lucknow 226001, UP, India.

Neurochemistry International

|August 3, 2011

Summary

Tiny non-coding RNAs, including small interfering RNA (siRNA) and micro RNA (miRNA), are crucial for understanding Parkinson's disease (PD) mechanisms and developing new therapies. Their roles in gene silencing offer promising avenues for PD research and treatment strategies.

Related Experiment Videos

Last Updated: May 30, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Area of Science:

Neuroscience
Molecular Biology
Genetics

Background:

Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting dopaminergic neurons.
Current understanding of PD's early diagnosis, molecular basis, and cure remains incomplete.

Purpose of the Study:

To review the role of tiny non-coding RNAs, specifically siRNA and miRNA, in Parkinson's disease.
To explore their potential in understanding PD pathogenesis and developing therapeutic interventions.

Main Methods:

Review of current literature on siRNA and miRNA in PD research.
Analysis of RNA interference mechanisms and gene silencing applications.
Discussion of differential miRNA expression patterns and their significance.

Main Results:

miRNAs act as regulators and potential biomarkers for PD, aiding in identifying therapeutic targets.
siRNAs enable gene silencing to investigate gene function in PD pathogenesis.
Tiny non-coding RNAs are instrumental in exploring PD etiology and molecular mechanisms.

Conclusions:

siRNA and miRNA represent promising tools for advancing Parkinson's disease research.
These non-coding RNAs offer potential therapeutic strategies and insights into PD mechanisms.
Further research into tiny non-coding RNAs is essential for addressing PD challenges.